The distribution of body mass index among individuals with and without schizophrenia

被引:326
|
作者
Allison, DB
Fontaine, KR
Heo, M
Mentore, JL
Cappelleri, JC
Chandler, LP
Weiden, PJ
Cheskin, LJ
机构
[1] St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA
[2] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA
关键词
D O I
10.4088/JCP.v60n0402
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The objective of this study was to estimate and compare the distributions of body mass index (BMI: kg/m(2)) among individuals with and without schizophrenia, and, thereby, place the weight gain-inducing effects of antipsychotic drugs into context. Method: Data sources were (1)the mental health supplement of the 1989 National Health Interview Survey (NHIS; N = 80,130 nonschizophrenic and 150 self-reported schizophrenic individuals), (2) baseline BMI data from a drug trial of the antipsychotic ziprasidone supplied by Pfizer Inc (420 noninstitutionalized individuals with chronic psychotic disorders [DSM-IV schizophrenia or schizoaffective disorder]) and (3) data from the National Health and Nutrition Examination Survey III (NHANES III; N = 17,689 nonschizophrenic individuals) to act as a control group for the ziprasidone trial data. Results: After age-adjusting BMI in each data set, the NHIS data revealed that men with schizophrenia have mean BMIs similar to those of men without schizophrenia (26.14 vs. 25.63, respectively). In contrast, women with schizophrenia in the NHIS data set had a significantly (p < .001) higher mean BMI than did women without schizophrenia (27.36 vs. 24.50, respectively). Moreover, each decile was higher for women with schizophrenia than for women without schizophrenia. Analysis of the ziprasidone and NHANES III data sets revealed that, on average, men with schizophrenia have mean BMIs comparable to those of men without schizophrenia (26.79 vs. 26.52, respectively). In these 2 data sets, women with schizophrenia also had a mean BMI similar to those of women without schizophrenia (27.29 vs. 27.39, respectively). Conclusion: Although there may be a small subpopulation of schizophrenic individuals who are underweight, individuals with schizophrenia were, on the whole, as obese as or more obese than individuals without schizophrenia, suggesting that weight gain induced by antipsychotic agents is an important concern for many individuals.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 50 条
  • [21] Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass index
    G. J. Hassing
    H. E. C. van der Wall
    G. J. P. van Westen
    M. J. B. Kemme
    A. Adiyaman
    A. Elvan
    J. Burggraaf
    P. Gal
    Netherlands Heart Journal, 2019, 27 : 506 - 512
  • [22] Body Mass Index Related Electrocardiographic Changes in Healthy, Young Individuals With a Normal Body Mass Index
    Gal, Pim
    Hassing, Gert Jan
    van der Wall, Hein E.
    van Westen, Gerard J.
    Kemme, Michiel J.
    Adiyaman, Ahmet
    Elvan, Arif
    Burggraaf, Jacobus
    CIRCULATION, 2018, 138
  • [23] Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass index
    Hassing, G. J.
    van der Wall, H. E. C.
    van Westen, G. J. P.
    Kemme, M. J. B.
    Adiyaman, A.
    Elvan, A.
    Burggraaf, J.
    Gal, P.
    NETHERLANDS HEART JOURNAL, 2019, 27 (10) : 506 - 512
  • [24] Genome-wide association study of body mass index in 23000 individuals with and without asthma
    Melen, E.
    Granell, R.
    Kogevinas, M.
    Strachan, D.
    Gonzalez, J. R.
    Wjst, M.
    Jarvis, D.
    Ege, M.
    Braun-Fahrlaender, C.
    Genuneit, J.
    Horak, E.
    Bouzigon, E.
    Demenais, F.
    Kauffmann, F.
    Siroux, V.
    Michel, S.
    von Berg, A.
    Heinzmann, A.
    Kabesch, M.
    Probst-Hensch, N. M.
    Curjuric, I.
    Imboden, M.
    Rochat, T.
    Henderson, J.
    Sterne, J. A. C.
    McArdle, W. L.
    Hui, J.
    James, A. L.
    Musk, A. William
    Palmer, L. J.
    Becker, A.
    Kozyrskyj, A. L.
    Chan-Young, M.
    Park, J. E.
    Leung, A.
    Daley, D.
    Freidin, M. B.
    Deev, I. A.
    Ogorodova, L. M.
    Puzyrev, V. P.
    Celedon, J. C.
    Brehm, J. M.
    Cloutier, M. M.
    Canino, G.
    Acosta-Perez, E.
    Soto-Quiros, M.
    Avila, L.
    Bergstrom, A.
    Magnusson, J.
    Soderhall, C.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (04): : 463 - 474
  • [25] Inflammation markers, endotelial function, age and body mass index in individuals without cardiovascular disease
    Garcia-Moll Marimon, Xavier
    MEDICINA CLINICA, 2008, 131 (10): : 378 - 379
  • [26] ASSOCIATIONS BETWEEN BODY MASS INDEX, WAIST TO HIP RATIO AND CONICITY INDEX, AMONG INDIVIDUALS ON MAINTENANCE HEMODIALYSIS
    Yeganehjoo, Maryam
    Byham-Gray, Laura
    Brody, Rebecca
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S77 - S77
  • [27] Comparisons of physical fitness and body composition among Sasang types with and without body mass index as a covariate
    Ko, You Sun
    You, Sung Eun
    INTEGRATIVE MEDICINE RESEARCH, 2015, 4 (01) : 41 - 47
  • [28] Body Mass Index, Obesity, and Psychopathology in Patients With Schizophrenia
    Subramaniam, Mythily
    Lam, Max
    Guo, Meng En
    He, Vincent Y. F.
    Lee, Jimmy
    Verma, Swapna
    Chong, Siow Ann
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 40 - 46
  • [29] The Effects of Hypertension and Body Mass Index on Cognition in Schizophrenia
    Friedman, Joseph I.
    Wallenstein, Sylvan
    Moshier, Erin
    Parrella, Michael
    White, Leonard
    Bowler, Stephanie
    Gottlieb, Stephanie
    McGinn, Thomas G.
    Flanagan, Lauren
    Davis, Kenneth L.
    AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (10): : 1232 - 1239
  • [30] Body mass index (BMI) and obesity in Nigerians with schizophrenia
    Esan, Oluyomi
    Esan, Arinola
    NORDIC JOURNAL OF PSYCHIATRY, 2022, 76 (01) : 12 - 17